OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 70 citing articles:

The Interplay between Insulin Resistance, Inflammation, Oxidative Stress, Base Excision Repair and Metabolic Syndrome in Nonalcoholic Fatty Liver Disease
Sylwia Ziółkowska, Agata Binienda, Maciej Jabłkowski, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11128-11128
Open Access | Times Cited: 111

The interplay between dietary fatty acids and gut microbiota influences host metabolism and hepatic steatosis
Marc Schoeler, Sandrine Ellero‐Simatos, Till Birkner, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 40

Updated mechanisms of MASLD pathogenesis
Yuxuan Li, Peipei Yang, Jialu Ye, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 30

The Metabolic Syndrome, a Human Disease
M. Alemany
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2251-2251
Open Access | Times Cited: 24

Global prevalence of nonalcoholic fatty liver disease: an updated meta-analysis on 78 million population over 38 countries
Ehsan Amini‐Salehi, Negin Letafatkar, Naeim Norouzi, et al.
Archives of Medical Research (2024) Vol. 55, Iss. 6, pp. 103043-103043
Closed Access | Times Cited: 21

Metabolic causes and consequences of nonalcoholic fatty liver disease (NAFLD)
Paria Zarghamravanbakhsh, Michael Frenkel, Leonid Poretsky
Metabolism Open (2021) Vol. 12, pp. 100149-100149
Open Access | Times Cited: 86

Ultra-Processed Food Intake Is Associated with Non-Alcoholic Fatty Liver Disease in Adults: A Systematic Review and Meta-Analysis
Alex E. Henney, Conor S. Gillespie, Uazman Alam, et al.
Nutrients (2023) Vol. 15, Iss. 10, pp. 2266-2266
Open Access | Times Cited: 31

Diet-derived and diet-related endogenously produced palmitic acid: Effects on metabolic regulation and cardiovascular disease risk
Carmen Annevelink, Philip A. Sapp, Kristina Petersen, et al.
Journal of clinical lipidology (2023) Vol. 17, Iss. 5, pp. 577-586
Open Access | Times Cited: 23

Ultra‐processed food and non‐communicable diseases in the United Kingdom: A narrative review and thematic synthesis of literature
Alex E. Henney, Conor S. Gillespie, Uazman Alam, et al.
Obesity Reviews (2024) Vol. 25, Iss. 4
Open Access | Times Cited: 8

Nonalcoholic fatty liver disease: lifestyle and quality of life
Ilias D. Vachliotis, A. Goulas, Paraskevi Papaioannidou, et al.
HORMONES (2021) Vol. 21, Iss. 1, pp. 41-49
Closed Access | Times Cited: 41

Gut commensal Kineothrix alysoides mitigates liver dysfunction by restoring lipid metabolism and gut microbial balance
Kyoung Jin Choi, Mi Young Yoon, Ji‐Eun Kim, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 15

Extracellular vesicle-mediated approaches for the diagnosis and therapy of MASLD: current advances and future prospective
Swasthika Gurjar, R. A., Raghavendra Upadhya, et al.
Lipids in Health and Disease (2025) Vol. 24, Iss. 1
Open Access

Current Therapeutic Landscape for Metabolic Dysfunction-Associated Steatohepatitis
Arun George Devasia, Adaikalavan Ramasamy, Chen Huei Leo
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1778-1778
Open Access

Insights into the roles and pathomechanisms of ceramide and sphigosine-1-phosphate in nonalcoholic fatty liver disease
Cheng Zhu, Qian Huai, Xu Zhang, et al.
International Journal of Biological Sciences (2022) Vol. 19, Iss. 1, pp. 311-330
Open Access | Times Cited: 23

Network Pharmacological Analysis of a New Herbal Combination Targeting Hyperlipidemia and Efficacy Validation In Vitro
Tae‐Hyoung Kim, Ga‐Ram Yu, Hyuck Kim, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 2, pp. 1314-1332
Open Access | Times Cited: 12

Association between dairy-rich dietary pattern and metabolic dysfunction-associated steatotic liver disease: Findings from the Korean Genome and Epidemiology Study
Jong Hee Lee, Hye Sun Lee, Soyoung Jeon, et al.
Digestive and Liver Disease (2024) Vol. 56, Iss. 9, pp. 1529-1536
Closed Access | Times Cited: 4

Cigarette Smoke Contributes to the Progression of MASLD: From the Molecular Mechanisms to Therapy
Jihao Xu, Yifan Li, Zhaolan Feng, et al.
Cells (2025) Vol. 14, Iss. 3, pp. 221-221
Open Access

Dietary composition and its association with metabolic dysfunction-associated fatty liver disease among Chinese adults: A cross-sectional study
Zuohu Niu, Jing Liu, Hongye Peng, et al.
Arab Journal of Gastroenterology (2024) Vol. 25, Iss. 2, pp. 205-213
Open Access | Times Cited: 3

Hepatic steatosis induced by nicotine plus Coca-Cola™ is prevented by nicotinamide riboside (NR)
Juan Carlos H Hernández-Rivera, Jorge Espinoza‐Derout, Kamrul M. Hasan, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 3

Correlation between non-alcoholic fatty liver disease and metabolic parameters in persons with newly diagnosed type 2 diabetes mellitus
Supriyo Mukherjee, Sushmita Mukherjee, Chun Shing Kwok, et al.
World Journal of Hepatology (2024) Vol. 16, Iss. 8, pp. 1120-1130
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top